PTH and osteoporosis: Therefore, one of the potential applications of the current model is its ability to investigate the effects of variations in BMU autocrine and paracrine rates as a result of a given treatment and dose, calcium–PTH regulation, etc. By performing iterative simulations on the effects of drug treatments and doses on bone volume, one can predict the optimal treatment strategy to reduce osteoporosis and fracture risk of a specific patient.